SEC Form 4 · accession 0000904454-18-000335
Inspire Medical Systems, Inc. · INSP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Period of report
May 7, 2018
Accepted (ET)
May 7, 2018 · 4:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001609550
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F4 | May 7, 2018 | C | 197,863 | — | A | 197,863 | I | By Johnson & Johnson Innovation - JJDC, Inc. |
| Common StockF1,F3,F4 | May 7, 2018 | C | 37,388 | — | A | 235,251 | I | By Johnson & Johnson Innovation - JJDC, Inc. |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series E Preferred StockF4,F1,F2 | — | May 7, 2018 | C | 1,145,038 | D | — | — | Common Stock | 197,863 | 0 | I |
| Series F Preferred StockF4,F1,F3 | — | May 7, 2018 | C | 248,631 | D | — | — | Common Stock | 37,388 | 0 | I |
Explanation of responses
- F1Shares of Series E and Series F Convertible Preferred Stock have no expiration date and were automatically converted into shares of Common Stock for no additional consideration immediately prior to the closing of the Issuer's initial public offering.
- F2Shares of Series E Convertible Preferred Stock converted into shares of Common Stock at a 1-for-0.1728 conversion rate.
- F3Shares of Series F Convertible Preferred Stock converted into shares of Common Stock at a 1-for-0.1504 conversion rate.
- F4The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc., a wholly-owned subsidiary of the designated Reporting Person.